| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 08/22/2002 | US20020115635 Modulation of GSK-3beta activity and its different uses |
| 08/21/2002 | CN1365361A Fused imiazole compounds and remedies for diabetes mellitus |
| 08/21/2002 | CN1365360A Puring derivatives inhibitors of tyrosine kinase SYK |
| 08/20/2002 | US6437125 Process for the production of purine derivatives |
| 08/20/2002 | US6437124 Xanthine derivatives which inhibit expression of adhesion molecules on human umbilical vein endothelial cell (huvec) monolayers at very low concentrations |
| 08/20/2002 | US6436947 Trans cyclopentanyl purine analogs useful as immunosuppressants |
| 08/20/2002 | US6436945 Substituted O6-benzyl-8-aza-guanines |
| 08/20/2002 | CA2257222C Amide derivatives |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2001028545A9 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 08/14/2002 | EP1231211A1 Thiazolidinedione derivatives as antidiabetic agents |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230242A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001036419A9 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/01/2002 | WO2002059125A1 Cyclin dependent kinase inhibiting purine derivatives |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | US20020103214 Novel heteroaryl derivatives and their use as medicaments |
| 08/01/2002 | US20020103209 Serotonergic modulators; for treatment of disorders of the central nervous system including psychotic disorders, hypertension and vascular disorders, migraine |
| 08/01/2002 | CA2434085A1 Cyclin dependent kinase inhibiting purine derivatives |
| 07/31/2002 | EP1225877A2 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
| 07/31/2002 | CN1361780A Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 07/30/2002 | US6426337 Antiinflammatory agents |
| 07/25/2002 | WO2002057425A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057287A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | US20020099054 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 07/25/2002 | US20020099030 Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423716 Nitrogenous heterocyclic compounds |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/18/2002 | WO2002055521A1 Purine derivatives as purinergic receptor antagonists |
| 07/18/2002 | US20020095044 Substituted isoindolinone derivatives |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP0817637B1 Synergistic combinations of zidovudine, 1592u89 and 3tc |
| 07/17/2002 | EP0801568B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | US20020091263 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 07/11/2002 | US20020091163 Triptycene analogs |
| 07/11/2002 | US20020091122 Voltage-dependent |
| 07/10/2002 | EP1221444A1 Fused imidazole compounds and remedies for diabetes mellitus |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1098657B1 Green tea extracts containing catechols and caffeine |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358190A Propargyl phenyl ether A2A receptor agonists |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/09/2002 | US6417217 Prolines as antimicrobial agents |
| 07/09/2002 | US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC |
| 07/09/2002 | US6417180 Zinc finger-reactive antimicrobial compounds |
| 07/09/2002 | CA2101640C Pharmaceuticals |
| 07/04/2002 | WO2002051843A1 Novel purine derivatives, preparation method and use as medicines |
| 07/04/2002 | US20020086850 Antiinflammatory agents |
| 07/04/2002 | US20020085019 Data-driven layout engine |
| 07/04/2002 | CA2433220A1 Novel purine derivatives, preparation method and use as medicines |
| 07/03/2002 | EP1219607A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP0777669B1 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent |
| 07/02/2002 | US6414147 2-amino-9-alkylpurines: GABA brain receptor ligands |
| 07/02/2002 | US6414013 Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| 07/02/2002 | US6413975 Purine derivatives having phosphodiesterase iv inhibition activity |
| 07/02/2002 | US6413974 Inhibitors of cyclin dependent kinases, particularly cdk-2; preventing apoptosis in neuronal cells; antineoplastic agents; neuronal injury and degeneration; cerebrovascular disease |
| 07/02/2002 | US6413962 Anesthesia and temperatures reduction; alpha-adrenoceptor agonist; restorative to central nervous system, especially motor and sensory functional losses from tramatic spinal cord injuries; antispastics; nonsedative; side effect reduction |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050062A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 06/27/2002 | WO2002022602A3 Triazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002009648A3 Antimicrobial biaryl compounds |
| 06/27/2002 | US20020082269 Purine-2,6-dione based compounds as receptor binding assay probes and pharmaceuticals; high potency and affinity with water solubility |
| 06/27/2002 | DE10137038A1 N-3,7 Substituted 1-Methylxanthine Derivates Displaying Inhibitory Activites on Type Five Phosphodiesterase N-Substituted 3,7-methylxanthine derivative Displaying 1 Inhibitory Activites on phosphodiesterase Type Five |
| 06/27/2002 | CA2431592A1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 06/26/2002 | EP1216257A1 Compounds for the treatment of ischemia |
| 06/26/2002 | EP0909270B1 Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/26/2002 | CN1086704C Compound having antihypertensive, cardioprotective, anti-ischemic and ant ilipolytic functions |
| 06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077271 Compounds and methods of use to treat infectious diseases |
| 06/19/2002 | EP1214938A2 Modulation of cellular response to external stimuli |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/19/2002 | CN1086386C Multi-drug resistance modifier |
| 06/18/2002 | US6407237 Crystal forms of 9-substituted hypoxanthine derivatives |
| 06/13/2002 | WO2002046240A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/13/2002 | WO2002045707A2 Polynucleotide intercalator interceptors and inhibitors |